Human Fibroblast Interferon for Clinical Trials: Production, Partial Purification, and Characterization

The production and partial purification of human fibroblast interferon for performing clinical trials is described. The interferon was produced by superinduction (exposure to riboinosinic-ribocytidylic acid, cycloheximide, and actinomycin D) of large numbers of human diploid fibroblast cultures. The...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Billiau, Alfons, Van Damme, Jo, Van Leuven, Fred, Edy, Victor G., De Ley, Marc, Cassiman, Jean-Jacques, Van Den Berghe, Herman, De Somer, Piet
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1979
主題:	Biosynthesis; Chemistry; Mechanisms of Action and Resistance
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352787/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/475374/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.1.49
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!